$NHI
National Health Investors Inc Stock $nhi

$nhi Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-K Financial Statement

#000087786017000017 Filed on February 17, 2017

Income Statement

Concept	2016 Q4	2016	2015 Q4
Revenue	$64.99M	$248.5M	$58.64M
YoY Change	10.82%	8.52%	28.22%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.750M	$11.20M	$3.270M
YoY Change	-15.9%	-6.67%	59.51%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$15.80M	$59.53M	$13.70M
YoY Change	15.33%	12.05%	41.24%
% of Gross Profit
Operating Expenses	$18.61M	$129.7M	$16.93M
YoY Change	9.92%	26.87%	43.96%
Operating Profit
YoY Change
Interest Expense	-$5.180M	$43.11M	$12.37M
YoY Change	-141.88%	14.56%	-310.37%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$700.0K	$710.0K
YoY Change	-100.0%	-200.0%
Pretax Income	$41.19M	$118.8M	$54.79M
YoY Change	-24.82%	-6.28%	94.98%
Income Tax		$854.0K
% Of Pretax Income		0.72%
Net Earnings	$41.19M	$151.5M	$54.40M
YoY Change	-24.28%	1.8%	97.58%
Net Earnings / Revenue	63.38%	60.99%	92.76%
Basic Earnings Per Share	$1.03	$3.88	$1.44
Diluted Earnings Per Share	$1.03	$3.87	$1.44
COMMON SHARES
Basic Shares Outstanding	39.85M shares	39.01M shares	37.73M shares
Diluted Shares Outstanding	39.99M shares	39.16M shares	37.74M shares

Balance Sheet

Concept	2016 Q4	2016	2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.58M	$4.800M	$24.84M
YoY Change	-33.25%	-63.91%	33.56%
Cash & Equivalents	$4.832M	$4.800M	$13.09M
Short-Term Investments	$11.75M		$11.75M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$9.212M	$9.000M	$3.260M
Other Receivables	$72.50M	$72.50M	$59.70M
Total Short-Term Assets	$86.30M	$86.30M	$76.30M
YoY Change	13.11%	13.11%	80.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.160B	$2.160B	$1.837B
YoY Change	17.58%	17.58%	3.39%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$11.70M	$7.657M
YoY Change	-100.0%	-85.45%	-18.75%
Other Assets	$4.000M	$4.000M	$6.000M
YoY Change	-33.33%	-33.33%	-76.92%
Total Long-Term Assets	$2.317B	$2.317B	$2.057B
YoY Change	12.66%	12.66%	5.99%
TOTAL ASSETS
Total Short-Term Assets	$86.30M	$86.30M	$76.30M
Total Long-Term Assets	$2.317B	$2.317B	$2.057B
Total Assets	$2.404B	$2.404B	$2.133B
YoY Change	12.68%	12.68%	7.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.00M	$20.00M	$19.40M
YoY Change	3.09%	3.09%	23.57%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$77.20M	$77.20M	$73.30M
YoY Change	5.32%	5.32%	10.73%
LONG-TERM LIABILITIES
Long-Term Debt	$1.116B	$1.116B	$914.4M
YoY Change	22.05%	22.05%	5.99%
Other Long-Term Liabilities	$900.0K	$900.0K	$3.000M
YoY Change	-70.0%	-70.0%	-26.83%
Total Long-Term Liabilities	$1.117B	$1.117B	$917.4M
YoY Change	21.75%	21.75%	5.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$77.20M	$77.20M	$73.30M
Total Long-Term Liabilities	$1.117B	$1.117B	$917.4M
Total Liabilities	$1.194B	$1.194B	$990.8M
YoY Change	20.52%	19.41%	6.19%
SHAREHOLDERS EQUITY
Retained Earnings	$29.87M		$19.86M
YoY Change	50.4%
Common Stock	$1.174B		$1.086B
YoY Change	8.15%		4.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.210B	$1.210B	$1.133B
YoY Change
Total Liabilities & Shareholders Equity	$2.404B	$2.404B	$2.133B
YoY Change	12.68%	12.68%	7.58%

Cashflow Statement

Concept	2016 Q4	2016	2015 Q4
OPERATING ACTIVITIES
Net Income	$41.19M	$151.5M	$54.40M
YoY Change	-24.28%	1.8%	97.58%
Depreciation, Depletion And Amortization	$15.80M	$59.53M	$13.70M
YoY Change	15.33%	12.05%	41.24%
Cash From Operating Activities	$47.30M	$176.6M	$43.60M
YoY Change	8.49%	7.43%	32.52%
INVESTING ACTIVITIES
Capital Expenditures	-$70.30M	$394.7M	-$2.200M
YoY Change	3095.45%	218.05%	-99.55%
Acquisitions
YoY Change
Other Investing Activities	$40.60M	$29.40M	$24.70M
YoY Change	64.37%	-198.0%	-374.44%
Cash From Investing Activities	-$29.60M	-$329.8M	$22.40M
YoY Change	-232.14%	141.95%	-104.54%
FINANCING ACTIVITIES
Cash Dividend Paid		$138.3M
YoY Change		10.95%
Common Stock Issuance & Retirement, Net		$104.2M
YoY Change		112.14%
Debt Paid & Issued, Net		$767.0K
YoY Change		3.37%
Cash From Financing Activities	-17.60M	$144.2M	-67.00M
YoY Change	-73.73%	-896.49%	-114.55%
NET CHANGE
Cash From Operating Activities	47.30M	$176.6M	43.60M
Cash From Investing Activities	-29.60M	-$329.8M	22.40M
Cash From Financing Activities	-17.60M	$144.2M	-67.00M
Net Change In Cash	100.0K	-$9.035M	-1.000M
YoY Change	-110.0%	-190.36%	233.33%
FREE CASH FLOW
Cash From Operating Activities	$47.30M	$176.6M	$43.60M
Capital Expenditures	-$70.30M	$394.7M	-$2.200M
Free Cash Flow	$117.6M	-$218.1M	$45.80M
YoY Change	156.77%	-641.03%	-91.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016	dei	Amendment Flag AmendmentFlag	false
CY2016	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2016	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016	dei	Document Period End Date DocumentPeriodEndDate	2016-12-31
CY2016	dei	Document Type DocumentType	10-K
CY2016	dei	Entity Central Index Key EntityCentralIndexKey	0000877860
CY2017Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	39847860	shares
CY2016	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2016	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2016Q2	dei	Entity Public Float EntityPublicFloat	2819841000	USD
CY2016	dei	Entity Registrant Name EntityRegistrantName	NATIONAL HEALTH INVESTORS INC
CY2016	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2016	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2014	nhi	Additions Through Assumption Of Debt AdditionsThroughAssumptionOfDebt	7858000	USD
CY2015	nhi	Additions Through Assumption Of Debt AdditionsThroughAssumptionOfDebt	0	USD
CY2016	nhi	Additions Through Assumption Of Debt AdditionsThroughAssumptionOfDebt	0	USD
CY2016	nhi	Change In Accounts Payable Real Property Additions ChangeInAccountsPayableRealPropertyAdditions	-430000	USD
CY2014	nhi	Additions Through Contingent Liabilities AdditionsThroughContingentLiabilities	3000000	USD
CY2015	nhi	Additions Through Contingent Liabilities AdditionsThroughContingentLiabilities	-2250000	USD
CY2016	nhi	Additions Through Contingent Liabilities AdditionsThroughContingentLiabilities	0	USD
CY2014	nhi	Additions Through Reclassificationof Deposit AdditionsThroughReclassificationofDeposit	0	USD
CY2015	nhi	Additions Through Reclassificationof Deposit AdditionsThroughReclassificationofDeposit	0	USD
CY2016	nhi	Additions Through Reclassificationof Deposit AdditionsThroughReclassificationofDeposit	227000	USD
CY2014	nhi	Additions Through Settlement Of Mortgage Note AdditionsThroughSettlementOfMortgageNote	0	USD
CY2015	nhi	Additions Through Settlement Of Mortgage Note AdditionsThroughSettlementOfMortgageNote	255000	USD
CY2016	nhi	Additions Through Settlement Of Mortgage Note AdditionsThroughSettlementOfMortgageNote	9753000	USD
CY2014	nhi	Aggregate Intrinsic Value Per Share Optionsexercised AggregateIntrinsicValuePerShareOptionsexercised	15.51
CY2015	nhi	Aggregate Intrinsic Value Per Share Optionsexercised AggregateIntrinsicValuePerShareOptionsexercised	12.69
CY2016	nhi	Aggregate Intrinsic Value Per Share Optionsexercised AggregateIntrinsicValuePerShareOptionsexercised	7.06
CY2014	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	2580000	USD
CY2015	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	3413000	USD
CY2016	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	3514000	USD
CY2014	nhi	Cash Paid In Settlement Of Contingent Purchase Consideration Liability CashPaidInSettlementOfContingentPurchaseConsiderationLiability	2600000	USD
CY2015	nhi	Cash Paid In Settlement Of Contingent Purchase Consideration Liability CashPaidInSettlementOfContingentPurchaseConsiderationLiability	0	USD
CY2016	nhi	Cash Paid In Settlement Of Contingent Purchase Consideration Liability CashPaidInSettlementOfContingentPurchaseConsiderationLiability	0	USD
CY2014	nhi	Change In Accounts Payable Real Property Additions ChangeInAccountsPayableRealPropertyAdditions	-995000	USD
CY2015	nhi	Change In Accounts Payable Real Property Additions ChangeInAccountsPayableRealPropertyAdditions	1076000	USD
CY2014	nhi	Common Stock Dividends Per Share Declared Regular CommonStockDividendsPerShareDeclaredRegular	3.08
CY2015	nhi	Common Stock Dividends Per Share Declared Regular CommonStockDividendsPerShareDeclaredRegular	3.40
CY2016	nhi	Common Stock Dividends Per Share Declared Regular CommonStockDividendsPerShareDeclaredRegular	3.60
CY2016	nhi	Common Stock Ownership Limit CommonStockOwnershipLimit	0.099
CY2016	nhi	Convertible Debt Instrument Conversion Ratio Principal Amount Basis ConvertibleDebtInstrumentConversionRatioPrincipalAmountBasis	1000	USD
CY2016Q4	nhi	Credit Facility Current Revolving Borrowing Capacity CreditFacilityCurrentRevolvingBorrowingCapacity	550000000	USD
CY2016Q4	nhi	Debt Instrument Variable Interest Rate Reference Rate Basis Points DebtInstrumentVariableInterestRateReferenceRateBasisPoints	77
CY2014	nhi	Dividend Income On Marketable Securities DividendIncomeOnMarketableSecurities	716000	USD
CY2015	nhi	Dividend Income On Marketable Securities DividendIncomeOnMarketableSecurities	1330000	USD
CY2016	nhi	Dividend Income On Marketable Securities DividendIncomeOnMarketableSecurities	1697000	USD
CY2016	nhi	Entity Incorporate Date Of Incorporation Year EntityIncorporateDateOfIncorporationYear	1991
CY2014	nhi	Escrow Deposits Dueto Increase In Accounts Payable EscrowDepositsDuetoIncreaseInAccountsPayable	2062000	USD
CY2015	nhi	Escrow Deposits Dueto Increase In Accounts Payable EscrowDepositsDuetoIncreaseInAccountsPayable	0	USD
CY2016	nhi	Escrow Deposits Dueto Increase In Accounts Payable EscrowDepositsDuetoIncreaseInAccountsPayable	0	USD
CY2016	nhi	Excepted Holder Agreement Common Stock Ownership Limit ExceptedHolderAgreementCommonStockOwnershipLimit	0.075
CY2014	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	605000	USD
CY2015	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	985000	USD
CY2016	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	1009000	USD
CY2014	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	0	USD
CY2015	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	-491000	USD
CY2015	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	-491000	USD
CY2016	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	15856000	USD
CY2016Q4	nhi	Maximum Commitment For All Active Development Projects MaximumCommitmentForAllActiveDevelopmentProjects	128300000	USD
CY2014	nhi	Mortgage Loans On Real Estate Total Additions MortgageLoansOnRealEstateTotalAdditions	1238000	USD
CY2015	nhi	Mortgage Loans On Real Estate Total Additions MortgageLoansOnRealEstateTotalAdditions	83747000	USD
CY2016	nhi	Mortgage Loans On Real Estate Total Additions MortgageLoansOnRealEstateTotalAdditions	67115000	USD
CY2014	nhi	Mortgage Loans On Real Estate Total Deductions MortgageLoansOnRealEstateTotalDeductions	1314000	USD
CY2015	nhi	Mortgage Loans On Real Estate Total Deductions MortgageLoansOnRealEstateTotalDeductions	17473000	USD
CY2014	nhi	Settlement Of Mortgage Note By Real Estate Acquisition SettlementOfMortgageNoteByRealEstateAcquisition	0	USD
CY2015	nhi	Settlement Of Mortgage Note By Real Estate Acquisition SettlementOfMortgageNoteByRealEstateAcquisition	1545000	USD
CY2016	nhi	Settlement Of Mortgage Note By Real Estate Acquisition SettlementOfMortgageNoteByRealEstateAcquisition	0	USD
CY2016	nhi	Mortgage Loans On Real Estate Total Deductions MortgageLoansOnRealEstateTotalDeductions	69060000	USD
CY2014	nhi	Net Assets Received In Acquisitionof Equity Method Investee NetAssetsReceivedInAcquisitionofEquityMethodInvestee	-10304000	USD
CY2015	nhi	Net Assets Received In Acquisitionof Equity Method Investee NetAssetsReceivedInAcquisitionofEquityMethodInvestee	-6062000	USD
CY2016	nhi	Net Assets Received In Acquisitionof Equity Method Investee NetAssetsReceivedInAcquisitionofEquityMethodInvestee	-1506000	USD
CY2016	nhi	Nonemployeedirectorannualstockgrants Nonemployeedirectorannualstockgrants	20000	shares
CY2016Q4	nhi	Nonportfolio Assets Original Cost NonportfolioAssetsOriginalCost	1175000	USD
CY2016Q4	nhi	Number Of Health Care Properties Related To Mortgage Notes Receivables NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables	8	properties
CY2016Q4	nhi	Number Of Lessees NumberOfLessees	27
CY2014	nhi	Paymentsintofacilityrepairescrows Paymentsintofacilityrepairescrows	1554000	USD
CY2015	nhi	Paymentsintofacilityrepairescrows Paymentsintofacilityrepairescrows	0	USD
CY2016	nhi	Paymentsintofacilityrepairescrows Paymentsintofacilityrepairescrows	0	USD
CY2016Q4	nhi	Real Estate Investment Property Portfolio Assets RealEstateInvestmentPropertyPortfolioAssets	2471679000	USD
CY2016	nhi	Real Estate Investments Completed During The Period RealEstateInvestmentsCompletedDuringThePeriod	395163000	USD
CY2016Q4	nhi	Remaining Unfunded Development Commitment RemainingUnfundedDevelopmentCommitment	72853000	USD
CY2014	nhi	Settlementof Contingent Asset Acquisition Liability SettlementofContingentAssetAcquisitionLiability	3000000	USD
CY2015	nhi	Settlementof Contingent Asset Acquisition Liability SettlementofContingentAssetAcquisitionLiability	750000	USD
CY2016	nhi	Settlementof Contingent Asset Acquisition Liability SettlementofContingentAssetAcquisitionLiability	0	USD
CY2015Q4	nhi	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedNumber	265013	shares
CY2016Q4	nhi	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedNumber	353348	shares
CY2014	nhi	Taxdeferredexchangefundsappliedtoinvestmentinrealestate Taxdeferredexchangefundsappliedtoinvestmentinrealestate	23813000	USD
CY2015	nhi	Taxdeferredexchangefundsappliedtoinvestmentinrealestate Taxdeferredexchangefundsappliedtoinvestmentinrealestate	0	USD
CY2016	nhi	Taxdeferredexchangefundsappliedtoinvestmentinrealestate Taxdeferredexchangefundsappliedtoinvestmentinrealestate	0	USD
CY2014	nhi	Unsettled Marketable Securities Sales Transactions UnsettledMarketableSecuritiesSalesTransactions	0	USD
CY2015	nhi	Unsettled Marketable Securities Sales Transactions UnsettledMarketableSecuritiesSalesTransactions	0	USD
CY2016	nhi	Unsettled Marketable Securities Sales Transactions UnsettledMarketableSecuritiesSalesTransactions	6464000	USD
CY2016	nhi	Variable Interest Entity Number Of Entities Not Primary Beneficiary VariableInterestEntityNumberOfEntitiesNotPrimaryBeneficiary	7
CY2014	nhi	Writeoffof Unamortized Debt Premium WriteoffofUnamortizedDebtPremium	1655000	USD
CY2015	nhi	Writeoffof Unamortized Debt Premium WriteoffofUnamortizedDebtPremium	0	USD
CY2016	nhi	Writeoffof Unamortized Debt Premium WriteoffofUnamortizedDebtPremium	0	USD
CY2015Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	20147000	USD
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	20003000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3260000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9017000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	27910000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5731000	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1085136000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1173588000	USD
CY2016	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1133000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	7487000	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2020000	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2134000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1732000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2014	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	107000	USD
CY2015	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	336000	USD
CY2016	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	669000	USD
CY2014	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	0	USD
CY2015	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	0	USD
CY2016	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	693000	USD
CY2014	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2611000	USD
CY2015	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3472000	USD
CY2016	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3563000	USD
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13831	shares
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	51603	shares
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6366	shares
CY2015Q4	us-gaap	Assets Assets	2133218000	USD
CY2016Q4	us-gaap	Assets Assets	2403633000	USD
CY2015Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	1346000	USD
CY2016Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	34667000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	10065000	USD
CY2014	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax	2853000	USD
CY2015	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax	23251000	USD
CY2016	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax	-24601000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11312000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3287000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13286000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4832000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-8025000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	9999000	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-8454000	USD
CY2016	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	2680000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.08
CY2015	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.40
CY2016	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.60
CY2014	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	3.08
CY2015	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	3.40
CY2016	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	3.60
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38396727	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39847860	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38396727	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39847860	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	384000	USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	398000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	98294000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	170549000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	129361000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1443000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1452000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1176000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	99737000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	172001000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	130537000	USD
CY2015Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	13011000	USD
CY2016Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	15729000	USD
CY2014	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2015	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	38132000	USD
CY2016	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2014Q1	us-gaap	Convertible Debt ConvertibleDebt	192238000	USD
CY2015Q4	us-gaap	Convertible Debt ConvertibleDebt	194138000	USD
CY2016Q4	us-gaap	Convertible Debt ConvertibleDebt	195283000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	42000	USD
CY2014Q1	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	7762000	USD
CY2016Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	70.93
CY2016	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	14.10
CY2016	us-gaap	Debt Instrument Convertible If Converted Value In Excess Of Principal DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal	9137000	USD
CY2016	us-gaap	Debt Instrument Convertible Number Of Equity Instruments DebtInstrumentConvertibleNumberOfEquityInstruments	2819785	shares
CY2016Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.039
CY2016Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	6204000	USD
CY2015Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	914443000	USD
CY2016Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1115981000	USD
CY2015Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	15544000	USD
CY2016Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	21271000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	707000	USD
CY2015Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	59777000	USD
CY2016Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	72518000	USD
CY2015Q4	us-gaap	Deferred Revenue DeferredRevenue	2256000	USD
CY2016Q4	us-gaap	Deferred Revenue DeferredRevenue	871000	USD
CY2014	us-gaap	Depreciation Depreciation	38078000	USD
CY2015	us-gaap	Depreciation Depreciation	53163000	USD
CY2016	us-gaap	Depreciation Depreciation	59565000	USD
CY2016Q4	us-gaap	Development In Process DevelopmentInProcess	55447000	USD
CY2014	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	105221000	USD
CY2015	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	128431000	USD
CY2016	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	141529000	USD
CY2015Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	32637000	USD
CY2016Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	35863000	USD
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.04
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.83
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.89
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.44
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.96
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.85
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.16
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.84
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.03
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.88
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.04
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.79
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.83
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.89
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.44
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.95
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.85
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.16
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.83
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.03
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.87
CY2016Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	399000	USD
CY2014	us-gaap	Equity Method Investment Sold Carrying Amount EquityMethodInvestmentSoldCarryingAmount	0	USD
CY2015	us-gaap	Equity Method Investment Sold Carrying Amount EquityMethodInvestmentSoldCarryingAmount	0	USD
CY2016	us-gaap	Equity Method Investment Sold Carrying Amount EquityMethodInvestmentSoldCarryingAmount	8100000	USD
CY2015Q4	us-gaap	Equity Method Investments EquityMethodInvestments	7657000	USD
CY2016Q4	us-gaap	Equity Method Investments EquityMethodInvestments	0	USD
CY2015Q4	us-gaap	Escrow Deposit EscrowDeposit	4627000	USD
CY2016Q4	us-gaap	Escrow Deposit EscrowDeposit	4046000	USD
CY2014	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	0	USD
CY2015	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	0	USD
CY2016	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	227000	USD
CY2014	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	0	USD
CY2015	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	1126000	USD
CY2016	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	4582000	USD
CY2014	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	0	USD
CY2015	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	0	USD
CY2016	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	1657000	USD
CY2014	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	0	USD
CY2015	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	1126000	USD
CY2016	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	4582000	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9107000	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10519000	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9773000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	103138000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	126719000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	118767000	USD
CY2014	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-71000	USD
CY2014	us-gaap	Income Loss From Subsidiaries Tax Expense Benefit IncomeLossFromSubsidiariesTaxExpenseBenefit	15000	USD
CY2015	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1767000	USD
CY2016	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1214000	USD
CY2015	us-gaap	Income Loss From Subsidiaries Tax Expense Benefit IncomeLossFromSubsidiariesTaxExpenseBenefit	-707000	USD
CY2015	us-gaap	Income Loss From Subsidiaries Tax Expense Benefit IncomeLossFromSubsidiariesTaxExpenseBenefit	-707000	USD
CY2016	us-gaap	Income Loss From Subsidiaries Tax Expense Benefit IncomeLossFromSubsidiariesTaxExpenseBenefit	749000	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	118000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-583000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	854000	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	139000	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	122000	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	30000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1448000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1038000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2764000	USD
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2830000	USD
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2501000	USD
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1385000	USD
CY2014	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	0	USD
CY2015	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	0	USD
CY2016	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	8208000	USD
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2334000	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-216000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1018000	USD
CY2014	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	4735	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	89471	shares
CY2014	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	40048	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	34842	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	52497	shares
CY2014	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	576000	USD
CY2015	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	357000	USD
CY2016	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	549000	USD
CY2014	us-gaap	Interest Expense InterestExpense	26372000	USD
CY2015	us-gaap	Interest Expense InterestExpense	37629000	USD
CY2016	us-gaap	Interest Expense InterestExpense	43108000	USD
CY2014	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	23878000	USD
CY2015	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	34573000	USD
CY2016	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	40143000	USD
CY2014	us-gaap	Interest Income Operating InterestIncomeOperating	7013000	USD
CY2015	us-gaap	Interest Income Operating InterestIncomeOperating	10206000	USD
CY2016	us-gaap	Interest Income Operating InterestIncomeOperating	13805000	USD
CY2014	us-gaap	Interest Paid InterestPaid	22172000	USD
CY2015	us-gaap	Interest Paid InterestPaid	31289000	USD
CY2016	us-gaap	Interest Paid InterestPaid	39539000	USD
CY2014Q4	us-gaap	Interest Rate Cash Flow Hedge Liability At Fair Value InterestRateCashFlowHedgeLiabilityAtFairValue	5193000	USD
CY2015Q4	us-gaap	Interest Rate Cash Flow Hedge Liability At Fair Value InterestRateCashFlowHedgeLiabilityAtFairValue	6730000	USD
CY2015Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1945323000	USD
CY2016Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	2285122000	USD
CY2014	us-gaap	Investment Income Net InvestmentIncomeNet	4217000	USD
CY2015	us-gaap	Investment Income Net InvestmentIncomeNet	4335000	USD
CY2016	us-gaap	Investment Income Net InvestmentIncomeNet	2302000	USD
CY2015Q4	us-gaap	Land Land	137532000	USD
CY2016Q4	us-gaap	Land Land	172003000	USD
CY2014	us-gaap	Legal Fees LegalFees	209000	USD
CY2015	us-gaap	Legal Fees LegalFees	464000	USD
CY2016	us-gaap	Legal Fees LegalFees	422000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	990758000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	1194043000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2133218000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2403633000	USD
CY2015Q4	us-gaap	Line Of Credit LineOfCredit	34000000	USD
CY2016Q4	us-gaap	Line Of Credit LineOfCredit	158000000	USD
CY2014	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	-207000000	USD
CY2015	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	340000000	USD
CY2016	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	-124000000	USD
CY2016Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	800000000	USD
CY2016	us-gaap	Line Of Credit Facility Unused Capacity Commitment Fee Percentage LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage	40
CY2015Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	133714000	USD
CY2016Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	133493000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	1131925000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	519675000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	794000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	200908000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	408878000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	849000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	821000	USD
CY2015Q4	us-gaap	Marketable Securities MarketableSecurities	72744000	USD
CY2016Q4	us-gaap	Marketable Securities MarketableSecurities	11745000	USD
CY2014	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0	USD
CY2015	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	23529000	USD
CY2016	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	29673000	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	9168000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	0	USD
CY2014	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2049000	USD
CY2015	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2292000	USD
CY2016	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1565000	USD
CY2016	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	25100000	USD
CY2013Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	34926000	USD
CY2014Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	34850000	USD
CY2015Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	101124000	USD
CY2016Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	99179000	USD
CY2016Q4	us-gaap	Mortgage Loans On Real Estate Carrying Amount Of Mortgages MortgageLoansOnRealEstateCarryingAmountOfMortgages	99179000	USD
CY2014	us-gaap	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	1314000	USD
CY2015	us-gaap	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	15928000	USD
CY2016	us-gaap	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	69060000	USD
CY2014	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	1131000	USD
CY2015	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	83411000	USD
CY2016	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	66446000	USD
CY2016Q4	us-gaap	Mortgage Loans On Real Estate Principal Amount Of Delinquent Loans MortgageLoansOnRealEstatePrincipalAmountOfDelinquentLoans	0	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	406148000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-18100000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	144165000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-540316000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-136326000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-329838000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	126143000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	164425000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	177219000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	101609000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	29683000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	31182000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	33600000	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	54397000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	148862000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	32725000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	44595000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	33032000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	41188000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	151540000	USD
CY2014	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1443000	USD
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1452000	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1176000	USD
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	2091000	USD
CY2015	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	1076000	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	430000	USD
CY2016Q4	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	197	properties
CY2016Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	32
CY2014	us-gaap	Operating Expenses OperatingExpenses	74371000	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	102269000	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	129733000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	2643554000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	220416000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	207718000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	206856000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	209711000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	213157000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1585696000	USD
CY2014	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	166279000	USD
CY2015	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	214447000	USD
CY2016	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	232393000	USD
CY2016Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	462000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-6168000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-1564000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	2422000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3315000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	21687000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-22179000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	USD
CY2015	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	23529000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	29673000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-4136000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-4498000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-3928000	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-10304000	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-6062000	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-1506000	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	2853000	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	46780000	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	5072000	USD
CY2014	us-gaap	Other Noncash Income OtherNoncashIncome	0	USD
CY2015	us-gaap	Other Noncash Income OtherNoncashIncome	411000	USD
CY2016	us-gaap	Other Noncash Income OtherNoncashIncome	1021000	USD
CY2014	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	0	USD
CY2015	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	0	USD
CY2016	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	1657000	USD
CY2014	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
CY2015	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	24655000	USD
CY2016	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	35912000	USD
CY2014	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	0	USD
CY2015	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	3000000	USD
CY2016	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	0	USD
CY2014	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	4211000	USD
CY2015	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	3157000	USD
CY2016	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	3378000	USD
CY2014	us-gaap	Payments For Delayed Tax Exempt Exchange PaymentsForDelayedTaxExemptExchange	23813000	USD
CY2015	us-gaap	Payments For Delayed Tax Exempt Exchange PaymentsForDelayedTaxExemptExchange	0	USD
CY2016	us-gaap	Payments For Delayed Tax Exempt Exchange PaymentsForDelayedTaxExemptExchange	0	USD
CY2014	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	8443000	USD
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2608000	USD
CY2016	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	258000	USD
CY2014	us-gaap	Payments Of Dividends PaymentsOfDividends	100650000	USD
CY2015	us-gaap	Payments Of Dividends PaymentsOfDividends	124657000	USD
CY2016	us-gaap	Payments Of Dividends PaymentsOfDividends	138303000	USD
CY2015	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	275000	USD
CY2014	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2015	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2016	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1133000	USD
CY2014	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2015	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2016	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	6400000	USD
CY2014	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	0	USD
CY2015	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	0	USD
CY2016	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	17000000	USD
CY2014	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
CY2015	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	8458000	USD
CY2016	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
CY2014	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	4447000	USD
CY2015	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	92249000	USD
CY2016	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	92051000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	533171000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	124113000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	394737000	USD
CY2014	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	520505000	USD
CY2015	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	106315000	USD
CY2016	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	359257000	USD
CY2014	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	8455000	USD
CY2015	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	14641000	USD
CY2016	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	32102000	USD
CY2014	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2049000	USD
CY2015	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2292000	USD
CY2016	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1565000	USD
CY2014	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	130000000	USD
CY2015	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	325000000	USD
CY2016	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	75000000	USD
CY2014	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	200000000	USD
CY2015	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2016	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	270798000	USD
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	49114000	USD
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	104190000	USD
CY2014	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	38007000	USD
CY2015	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	78084000	USD
CY2016	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
CY2015	us-gaap	Proceeds From Recoveries Of Loan Previously Charged Off ProceedsFromRecoveriesOfLoanPreviouslyChargedOff	491000	USD
CY2014	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	1456000	USD
CY2015	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	21495000	USD
CY2016	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	84228000	USD
CY2014	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2015	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	57406000	USD
CY2016	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	59607000	USD
CY2014	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	0	USD
CY2015	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	9593000	USD
CY2016	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	27723000	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1000	USD
CY2014	us-gaap	Profit Loss ProfitLoss	103052000	USD
CY2015	us-gaap	Profit Loss ProfitLoss	150314000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	152716000	USD
CY2016	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P40Y0M0D
CY2013Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	174262000	USD
CY2014Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	212300000	USD
CY2015Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	259059000	USD
CY2016Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	313080000	USD
CY2014	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	0	USD
CY2015	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	1268000	USD
CY2016	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	0	USD
CY2014	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	0	USD
CY2015	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	5096000	USD
CY2016	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	5504000	USD
CY2014	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	0	USD
CY2015	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	13563000	USD
CY2016	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	27299000	USD
CY2016Q4	us-gaap	Real Estate Federal Income Tax Basis RealEstateFederalIncomeTaxBasis	2115967000	USD
CY2013Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1422002000	USD
CY2014Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1988849000	USD
CY2015Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	2095866000	USD
CY2016Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	2472854000	USD
CY2015Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	259059000	USD
CY2016Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	313080000	USD
CY2015Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2095866000	USD
CY2016Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2472854000	USD
CY2015Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1836807000	USD
CY2016Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	2159774000	USD
CY2014	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	0	USD
CY2015	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	2614000	USD
CY2016	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	0	USD
CY2015Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	USD
CY2015Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	USD
CY2015Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	1126000	USD
CY2015Q4	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	23529000	USD
CY2016Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	1665000	USD
CY2016Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	26415000	USD
CY2016Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	1657000	USD
CY2016Q4	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	6175000	USD
CY2015Q4	us-gaap	Regulatory Assets RegulatoryAssets	0	USD
CY2016Q4	us-gaap	Regulatory Assets RegulatoryAssets	8208000	USD
CY2014	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	328515000	USD
CY2015	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	742000	USD
CY2016	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	767000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	19862000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	29873000	USD
CY2014	us-gaap	Revenues Revenues	177509000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	871671	shares
CY2015Q1	us-gaap	Revenues Revenues	55751000	USD
CY2015Q2	us-gaap	Revenues Revenues	56313000	USD
CY2015Q3	us-gaap	Revenues Revenues	58282000	USD
CY2015Q4	us-gaap	Revenues Revenues	58642000	USD
CY2015	us-gaap	Revenues Revenues	228988000	USD
CY2016Q1	us-gaap	Revenues Revenues	59018000	USD
CY2016Q2	us-gaap	Revenues Revenues	61204000	USD
CY2016Q3	us-gaap	Revenues Revenues	63251000	USD
CY2016Q4	us-gaap	Revenues Revenues	65027000	USD
CY2016	us-gaap	Revenues Revenues	248500000	USD
CY2014	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	38038000	USD
CY2015	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	53123000	USD
CY2016	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	59525000	USD
CY2015Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	21275000	USD
CY2016Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	21325000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.050
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.047
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.062
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.215
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.178
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.191
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0063
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0098
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0091
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1988347	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	188331	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	63.56
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	465000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5551000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4730000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.93
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.74
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.65
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5657000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	516674	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	741676	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	541679	shares
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y9M22D
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y9M25D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y11M4D
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1998000	USD
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y7M9D
CY2015Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	4.98
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	3.99
CY2016Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39993445	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39155380	shares
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y5M10D
CY2016	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	39013412	shares
CY2016	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	0	USD
CY2014	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	33375966	shares
CY2015	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	37604594	shares
CY2013Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	59.20
CY2014Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	60.43
CY2015Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	65.84
CY2016Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	63.73
CY2014	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	270798000	USD
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	49389000	USD
CY2016	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	104190000	USD
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000	USD
CY2016Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	1000000	shares
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	1133292000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	1209590000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	777160000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1049933000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1142460000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1209590000	USD
CY2014	us-gaap	Straight Line Rent StraightLineRent	16463000	USD
CY2015	us-gaap	Straight Line Rent StraightLineRent	24623000	USD
CY2016	us-gaap	Straight Line Rent StraightLineRent	22198000	USD
CY2015Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	11814000	USD
CY2016Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	9740000	USD
CY2016Q4	us-gaap	Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums	-1317000	USD
CY2013Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	0	USD
CY2014Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	0	USD
CY2015Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	0	USD
CY2016Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	0	USD
CY2014	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	0	USD
CY2015	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	0	USD
CY2016	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	0	USD
CY2014	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	0	USD
CY2015	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	0	USD
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33416014	shares
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37645265	shares
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37607117	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37583141	shares
CY2015Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37741162	shares
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37644171	shares
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38414791	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38561384	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39651900	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33375966	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37558067	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37566221	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37566221	shares
CY2015Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37727868	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37604594	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38401647	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38520221	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39283919	shares
CY2016Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39847860	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39013412	shares
CY2014	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	2145000	USD
CY2015	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	0	USD
CY2016	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	0	USD
CY2016	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentration of Credit Risks</font><font style="font-family:inherit;font-size:10pt;"> - Our credit risks primarily relate to cash and cash equivalents and investments in mortgage and other notes receivable. Cash and cash equivalents are primarily held in bank accounts and overnight investments. We maintain our bank deposit accounts with large financial institutions in amounts that often exceed federally-insured limits. We have not experienced any losses in such accounts. Our mortgages and other notes receivable consist primarily of secured loans on facilities. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our financial instruments, principally our investments in marketable securities and notes receivable, are subject to the possibility of loss of the carrying values as a result of either the failure of other parties to perform according to their contractual obligations or changes in market prices which may make the instruments less valuable. We obtain collateral in the form of mortgage liens and other protective rights for notes receivable and continually monitor these rights in order to reduce such possibilities of loss. We evaluate the need to provide for reserves for potential losses on our financial instruments based on management’s periodic review of our portfolio on an instrument-by-instrument basis.</font></div></div>
CY2016	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications</font><font style="font-family:inherit;font-size:10pt;"> - We have reclassified, for all periods presented, certain loan commitment fees paid by our borrowers, which were previously accounted for as deferred revenues on our Consolidated Balance Sheet at December 31, 2015. The fees are included in our consolidated balance sheets as a reduction of the related loan receivable balance. The effect has been to reduce total assets and total liabilities by </font><font style="font-family:inherit;font-size:10pt;">$1,317,000</font><font style="font-family:inherit;font-size:10pt;"> on our Consolidated Balance Sheet as of December 31, 2015. See Note 15 for a description of recent accounting pronouncements which require reclassification of items previously presented. </font></div></div>
CY2016	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Deferred Income</font><font style="font-family:inherit;font-size:10pt;"> - Deferred income primarily includes non-refundable lease commitment fees received by us, which are amortized into income over the expected period of the related loan or lease. In the event that our financing commitment to a potential borrower or lessee expires, the related commitment fees are recognized into income immediately. Commitment fees may be charged based on the terms of the lease agreements and the creditworthiness of the parties.</font></div></div>
CY2016	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates -</font><font style="font-family:inherit;font-size:10pt;"> The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

Files In Submission

Name	View Source	Status
0000877860-17-000017-index-headers.html	Edgar Link	pending
0000877860-17-000017-index.html	Edgar Link	pending
0000877860-17-000017.txt	Edgar Link	pending
0000877860-17-000017-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nhi-12312016x10kex1027.htm	Edgar Link	pending
nhi-12312016x10kex1028.htm	Edgar Link	pending
nhi-12312016x10kex1036.htm	Edgar Link	pending
nhi-12312016x10kex1037.htm	Edgar Link	pending
nhi-12312016x10kex121.htm	Edgar Link	pending
nhi-12312016x10kex21.htm	Edgar Link	pending
nhi-12312016x10kex231.htm	Edgar Link	pending
nhi-12312016x10kex311.htm	Edgar Link	pending
nhi-12312016x10kex312.htm	Edgar Link	pending
nhi-12312016x10kex32.htm	Edgar Link	pending
nhi-12312016x10kex991.htm	Edgar Link	pending
nhi-12312016x10kq4.htm	Edgar Link	pending
nhi-1231201_chartx24853.jpg	Edgar Link	pending
nhi-20161231.xml	Edgar Link	completed
nhi-20161231.xsd	Edgar Link	pending
nhi-20161231_cal.xml	Edgar Link	unprocessable
nhi-20161231_def.xml	Edgar Link	unprocessable
nhi-20161231_lab.xml	Edgar Link	unprocessable
nhi-20161231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHI
National Health Investors Inc Stock $nhi

2016 Q4 Form 10-K Financial Statement

#000087786017000017 Filed on February 17, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI National Health Investors Inc Stock $nhi

2016 Q4 Form 10-K Financial Statement

#000087786017000017 Filed on February 17, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI
National Health Investors Inc Stock $nhi